The art and science of contemporary drug development.
作者信息
Gordon A J, Gilgore S G
出版信息
Prog Drug Res. 1972;16:194-210. doi: 10.1007/978-3-0348-7081-8_4.
PMID:4567340
Abstract
摘要
相似文献
1
The art and science of contemporary drug development.
Prog Drug Res. 1972;16:194-210. doi: 10.1007/978-3-0348-7081-8_4.
2
Introducing a new drug into clinical practice.将一种新药引入临床实践。
Anesthesiology. 1971 Aug;35(2):176-92. doi: 10.1097/00000542-197108000-00016.
3
The pharmaceutical revolution: its impact on science and society.制药革命：其对科学与社会的影响。
Science. 1969 Dec 5;166(3910):1227-33. doi: 10.1126/science.166.3910.1227.
4
The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.美国食品药品监督管理局的药品监管体系：对现行安全性和有效性要求的辩护
Int J Health Serv. 1974 Winter;4(1):95-107. doi: 10.2190/TW4Q-WEDA-2Q7V-RHAH.
5
Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.药物生物等效性。药物生物等效性研究小组给美国国会技术评估办公室的建议。
J Pharmacokinet Biopharm. 1974 Oct;2(5):433-66.
6
A European perspective on regulation and technology.欧洲对监管与技术的看法。
PDA J Pharm Sci Technol. 1997 May-Jun;51(3):104-10.
7
Compounding pharmacy industry has outgrown its regulatory system, ASHP and FDA say.美国卫生系统药师协会（ASHP）和美国食品药品监督管理局（FDA）表示，复方制药行业的发展已超出其监管体系。
Am J Health Syst Pharm. 2013 May 1;70(9):747-8. doi: 10.2146/news130033.
8
The Home Field Disadvantage.主场劣势。
Int J Pharm Compd. 2016 Jan-Feb;20(1):86-7.
9
Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry.
Int J Health Serv. 1974 Winter;4(1):147-55. doi: 10.2190/DCU8-7F68-E48J-4ER5.
10
International diversification and US regulatory controls in the pharmaceutical industry.制药行业的国际多元化与美国监管控制
Q Rev Econ Bus. 1982 Spring;22(1):101-10.
Zotero 插件